Supporting Treatment Adherence Readiness Through Training (START) for Patients with HIV on Antiretroviral Therapy
Study Protocol for a Randomized Controlled Trial
ResearchPosted on rand.org Apr 22, 2016Published in: Trials, 2016
A "new generation" adherence support program targets patients before they begin HIV treatment. If proven efficacious and cost effective, the program could give clinicians a model for assessing their patients' readiness to adhere to HIV treatment.
Study Protocol for a Randomized Controlled Trial
ResearchPosted on rand.org Apr 22, 2016Published in: Trials, 2016
Few HIV antiretroviral adherence interventions target patients before they start treatment, assess adherence readiness to determine the timing of treatment initiation, or tailor the amount of adherence support. The Supporting Treatment Adherence Readiness through Training (START) intervention, based on the information-motivation-behavioral skills model of behavior change, is designed to address these gaps with the inclusion of (1) brief pill-taking practice trials for enhancing pretreatment adherence counseling and providing a behavioral criterion for determining adherence readiness and the timing of treatment initiation and (2) a performance-driven dose regulation mechanism to tailor the amount of counseling to the individual needs of the patient and conserve resources. The primary aim of this randomized controlled trial is to examine the effects of START on antiretroviral adherence and HIV virologic suppression.
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.